TY - JOUR AU - Lund, A. AU - Knop, F. K. AU - Vilsboll, T. PY - 2014 DA - 2014// TI - Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities JO - Eur J Int Med VL - 25 UR - https://doi.org/10.1016/j.ejim.2014.03.005 DO - 10.1016/j.ejim.2014.03.005 ID - Lund2014 ER - TY - JOUR AU - Smits, M. M. AU - Tonneijck, L. AU - Muskiet, M. H. A. AU - Kramer, M. H. AU - Cahen, D. L. AU - Raalte, D. H. PY - 2016 DA - 2016// TI - Gastrointestinal actions of GLP-1 based therapies: glycaemic control beyond the pancreas JO - Diabetes Obes Metab VL - 18 UR - https://doi.org/10.1111/dom.12601 DO - 10.1111/dom.12601 ID - Smits2016 ER - TY - STD TI - Mertens KL, Kalsbeek A, Soeters MR, Eggink HM. Bile acid signaling pathways from the Enterohepatic circulation to the central nervous system. Front Neurosci. 2017. https://doi.org/10.3389/fnins.2017.00617. ID - ref3 ER - TY - JOUR AU - Hofmann, A. F. AU - Hagey, L. R. PY - 2008 DA - 2008// TI - Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics JO - Cell Mol Life Sci VL - 65 UR - https://doi.org/10.1007/s00018-008-7568-6 DO - 10.1007/s00018-008-7568-6 ID - Hofmann2008 ER - TY - JOUR AU - Yu, Q. AU - Jiang, Z. AU - Zhang, L. PY - 2018 DA - 2018// TI - Bile acid regulation: a novel therapeutic strategy in non-alcoholic fatty liver disease JO - Pharmacol Ther VL - 190 UR - https://doi.org/10.1016/j.pharmthera.2018.04.005 DO - 10.1016/j.pharmthera.2018.04.005 ID - Yu2018 ER - TY - JOUR AU - Adrian, T. E. AU - Gariballa, S. AU - Parekh, K. A. AU - Thomas, S. A. AU - Saadi, H. AU - Kaabi, J. PY - 2012 DA - 2012// TI - Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers JO - Diabetologia. VL - 55 UR - https://doi.org/10.1007/s00125-012-2593-2 DO - 10.1007/s00125-012-2593-2 ID - Adrian2012 ER - TY - JOUR AU - Broeders, E. P. AU - Nascimento, E. B. AU - Havekes, B. AU - Brans, B. AU - Roumans, K. H. AU - Tailleux, A. PY - 2015 DA - 2015// TI - The bile acid chenodeoxycholic acid increases human brown adipose tissue activity JO - Cell Metab VL - 22 UR - https://doi.org/10.1016/j.cmet.2015.07.002 DO - 10.1016/j.cmet.2015.07.002 ID - Broeders2015 ER - TY - JOUR AU - Wu, T. AU - Bound, M. J. AU - Standfield, S. D. AU - Gedulin, B. AU - Jones, K. L. AU - Horowitz, M. PY - 2013 DA - 2013// TI - Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans JO - Diabetes Obes Metab VL - 15 UR - https://doi.org/10.1111/dom.12043 DO - 10.1111/dom.12043 ID - Wu2013 ER - TY - JOUR AU - Hansen, M. AU - Scheltema, M. J. AU - Sonne, D. P. AU - Hansen, J. S. AU - Sperling, M. AU - Rehfeld, J. F. PY - 2016 DA - 2016// TI - Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion JO - Diabetes Obes Metab VL - 18 UR - https://doi.org/10.1111/dom.12648 DO - 10.1111/dom.12648 ID - Hansen2016 ER - TY - JOUR AU - Brighton, C. A. AU - Rievaj, J. AU - Kuhre, R. E. AU - Glass, L. L. AU - Schoonjans, K. AU - Holst, J. J. PY - 2015 DA - 2015// TI - Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors JO - Endocrinology. VL - 156 UR - https://doi.org/10.1210/en.2015-1321 DO - 10.1210/en.2015-1321 ID - Brighton2015 ER - TY - JOUR AU - Knop, F. K. PY - 2010 DA - 2010// TI - Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes? JO - Am J Physiol Endocrinol Metab VL - 299 UR - https://doi.org/10.1152/ajpendo.00137.2010 DO - 10.1152/ajpendo.00137.2010 ID - Knop2010 ER - TY - JOUR AU - Shapiro, H. AU - Kolodziejczyk, A. A. AU - Halstuch, D. AU - Elinav, E. PY - 2018 DA - 2018// TI - Bile acids in glucose metabolism in health and disease JO - J Exp Med VL - 215 UR - https://doi.org/10.1084/jem.20171965 DO - 10.1084/jem.20171965 ID - Shapiro2018 ER - TY - JOUR AU - Keller, J. AU - Trautmann, M. E. AU - Haber, H. AU - Tham, L. S. AU - Hunt, T. AU - Mace, K. PY - 2012 DA - 2012// TI - Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects JO - Regul Pept VL - 179 UR - https://doi.org/10.1016/j.regpep.2012.08.005 DO - 10.1016/j.regpep.2012.08.005 ID - Keller2012 ER - TY - JOUR AU - Smits, M. M. AU - Tonneijck, L. AU - Muskiet, M. H. AU - Hoekstra, T. AU - Kramer, M. H. AU - Diamant, M. PY - 2016 DA - 2016// TI - Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients JO - Diabetes Obes Metab VL - 18 UR - https://doi.org/10.1111/dom.12748 DO - 10.1111/dom.12748 ID - Smits2016 ER - TY - JOUR AU - Hu, Y. AU - Liu, J. AU - Zhang, H. AU - Xu, Y. AU - Hong, T. AU - Wang, G. PY - 2016 DA - 2016// TI - Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitus JO - Diabetes Metab VL - 42 UR - https://doi.org/10.1016/j.diabet.2016.04.005 DO - 10.1016/j.diabet.2016.04.005 ID - Hu2016 ER - TY - CHAP PY - 1999 DA - 1999// TI - Definition and classification of diabetes mellitus and its complications BT - Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus PB - WHO CY - Geneva ID - ref16 ER - TY - JOUR AU - Matthews, D. R. AU - Hosker, J. P. AU - Rudenski, A. S. AU - Naylor, B. A. AU - Treacher, D. F. AU - Turner, R. C. PY - 1985 DA - 1985// TI - Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man JO - Diabetologia. VL - 28 UR - https://doi.org/10.1007/BF00280883 DO - 10.1007/BF00280883 ID - Matthews1985 ER - TY - JOUR AU - Simren, M. AU - Bajor, A. AU - Gillberg, P. G. AU - Rudling, M. AU - Abrahamsson, H. PY - 2011 DA - 2011// TI - Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation-a double-blind study JO - Aliment Pharmacol Ther VL - 34 UR - https://doi.org/10.1111/j.1365-2036.2011.04675.x DO - 10.1111/j.1365-2036.2011.04675.x ID - Simren2011 ER - TY - JOUR AU - Rudling, M. AU - Camilleri, M. AU - Graffner, H. AU - Holst, J. J. AU - Rikner, L. PY - 2015 DA - 2015// TI - Specific inhibition of bile acid transport alters plasma lipids and GLP-1 JO - BMC Cardiovasc Disord VL - 15 UR - https://doi.org/10.1186/s12872-015-0070-9 DO - 10.1186/s12872-015-0070-9 ID - Rudling2015 ER - TY - JOUR AU - Bays, H. E. AU - Goldberg, R. B. AU - Truitt, K. E. AU - Jones, M. R. PY - 2008 DA - 2008// TI - Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects JO - Arch Intern Med VL - 168 UR - https://doi.org/10.1001/archinte.168.18.1975 DO - 10.1001/archinte.168.18.1975 ID - Bays2008 ER - TY - JOUR AU - Beysen, C. AU - Murphy, E. J. AU - Deines, K. AU - Chan, M. AU - Tsang, E. AU - Glass, A. PY - 2012 DA - 2012// TI - Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study JO - Diabetologia. VL - 55 UR - https://doi.org/10.1007/s00125-011-2382-3 DO - 10.1007/s00125-011-2382-3 ID - Beysen2012 ER - TY - JOUR AU - Karhus, M. L. AU - Bronden, A. AU - Sonne, D. P. AU - Vilsbøll, T. AU - Knop, F. K. PY - 2017 DA - 2017// TI - Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: a review JO - Diabetes Obes Metab VL - 19 UR - https://doi.org/10.1111/dom.12946 DO - 10.1111/dom.12946 ID - Karhus2017 ER - TY - JOUR AU - Scarpello, J. H. AU - Hodgson, E. AU - Howlett, H. C. PY - 1998 DA - 1998// TI - Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus JO - Diabet Med VL - 15 UR - https://doi.org/3.0.CO;2-A DO - 3.0.CO;2-A ID - Scarpello1998 ER - TY - STD TI - Napolitano A, Miller S, Nicholls AW, Baker D, Van Horn S, Thomas E, et al. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One. 2014. https://doi.org/10.1371/journal.pone.0100778. ID - ref24 ER - TY - JOUR AU - Andersen, E. H. P. AU - Hellström, K. PY - 1986 DA - 1986// TI - Cholesterol and bile acid metabolism in middle-aged diabetics JO - Diabete Metab VL - 12 ID - Andersen1986 ER - TY - JOUR AU - Cui, Y. M. AU - Guo, X. H. AU - Zhang, D. M. AU - Tham, L. S. AU - Tang, C. C. AU - Mace, K. PY - 2013 DA - 2013// TI - Pharmacokinetics, safety, and tolerability of single- and multiple-dose Exenatide once weekly in Chinese patients with type 2 diabetes mellitus JO - J Diabetes VL - 5 UR - https://doi.org/10.1111/1753-0407.12020 DO - 10.1111/1753-0407.12020 ID - Cui2013 ER - TY - JOUR AU - Ben-Shlomo, S. AU - Zvibel, I. AU - Rabinowich, L. AU - Goldiner, I. AU - Shlomai, A. AU - Santo, E. M. PY - 2013 DA - 2013// TI - Dipeptidyl peptidase 4-deficient rats have improved bile secretory function in high fat diet-induced steatosis JO - Dig Dis Sci VL - 58 UR - https://doi.org/10.1007/s10620-012-2455-2 DO - 10.1007/s10620-012-2455-2 ID - Ben-Shlomo2013 ER - TY - JOUR AU - Schaap, F. G. T. M. AU - Jansen, P. L. PY - 2014 DA - 2014// TI - Bile acid receptors as targets for drug development JO - Nat Rev Gastroenterol Hepatol VL - 11 UR - https://doi.org/10.1038/nrgastro.2013.151 DO - 10.1038/nrgastro.2013.151 ID - Schaap2014 ER - TY - JOUR AU - Lefebvre, P. AU - Cariou, B. AU - Lien, F. AU - Kuipers, F. AU - Staels, B. PY - 2009 DA - 2009// TI - Role of bile acids and bile acid receptors in metabolic regulation JO - Physiol Rev VL - 89 UR - https://doi.org/10.1152/physrev.00010.2008 DO - 10.1152/physrev.00010.2008 ID - Lefebvre2009 ER - TY - JOUR AU - Thomas, C. AU - Gioiello, A. AU - Noriega, L. AU - Strehle, A. AU - Oury, J. AU - Rizzo, G. PY - 2009 DA - 2009// TI - TGR5-mediated bile acid sensing controls glucose homeostasis JO - Cell Metab VL - 10 UR - https://doi.org/10.1016/j.cmet.2009.08.001 DO - 10.1016/j.cmet.2009.08.001 ID - Thomas2009 ER -